Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.1 |
mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |